Skip to main content
Erschienen in: Obesity Surgery 8/2016

04.01.2016 | Original Contributions

Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes

verfasst von: Felicity Thomas, Greg C. Smith, Jun Lu, Richard Babor, Michael Booth, Grant Beban, J. Geoffrey Chase, Rinki Murphy

Erschienen in: Obesity Surgery | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Bariatric surgery is an increasingly common option for control of type 2 diabetes (T2D) and obesity. Mechanisms underlying rapid improvement of T2D after different types of bariatric surgery are not clear. Caloric deprivation and altered levels of non-esterified fatty acid (NEFA) have been proposed. This study examines how sleeve gastrectomy (SG), Roux-en-Y gastric bypass (GBP) or matched hypocaloric diet (DT) achieves improvements in T2D by characterising components of the glucose metabolism and NEFA levels before and 3 days after each intervention.

Methods

Plasma samples at five time points during oral glucose tolerance test (OGTT) from subjects with T2D undergoing GBP (N = 11) or SG (N = 12) were analysed for C-peptide, insulin and glucose before surgery and 3-day post-intervention or after DT (N = 5). Fasting palmitic, linoleic, oleic and stearic acid were measured. C-peptide measurements were used to model insulin secretion rate (ISR) using deconvolution.

Results

Subjects who underwent GBP surgery experienced the greatest improvement in glycaemia (median reduction in blood glucose (BG) from basal by 29 % [IQR −57, −18]) and the greatest reduction in all NEFA measured. SG achieved improvement in glycaemia with lower ISR and reduction in all but palmitoleic acid. DT subjects achieved improvement in glycaemia with an increase in ISR, 105 % [IQR, 20, 220] and stearic acid.

Conclusions

GBP, SG and DT each improve glucose metabolism through different effects on pancreatic beta cell function, insulin sensitivity and free fatty acids.
Literatur
2.
Zurück zum Zitat Buchwald H et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–U81.CrossRefPubMed Buchwald H et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–U81.CrossRefPubMed
3.
Zurück zum Zitat Pories WJ et al. Who would have thought it—an operation proves to be the most effective therapy for adult-onset diabetes-mellitus. Ann Surg. 1995;222(3):339–52.CrossRefPubMedPubMedCentral Pories WJ et al. Who would have thought it—an operation proves to be the most effective therapy for adult-onset diabetes-mellitus. Ann Surg. 1995;222(3):339–52.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Isbell JM et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care. 2010;33(7):1438–42.CrossRefPubMedPubMedCentral Isbell JM et al. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care. 2010;33(7):1438–42.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Kashyap SR et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes. 2010;34(3):462–71.CrossRef Kashyap SR et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes. 2010;34(3):462–71.CrossRef
6.
Zurück zum Zitat Bayham BE et al. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy. Diabetes Technol Ther. 2012;14(1):30–4.CrossRefPubMed Bayham BE et al. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy. Diabetes Technol Ther. 2012;14(1):30–4.CrossRefPubMed
7.
Zurück zum Zitat Ramon JM et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg. 2012;16(6):1116–22.CrossRefPubMed Ramon JM et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg. 2012;16(6):1116–22.CrossRefPubMed
8.
Zurück zum Zitat Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1985;61(5):917–25.CrossRefPubMed Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1985;61(5):917–25.CrossRefPubMed
9.
Zurück zum Zitat Lim EL et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–14.CrossRefPubMedPubMedCentral Lim EL et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–14.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Salinari S et al. Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. Diabetologia. 2008;51(7):1276–84.CrossRefPubMed Salinari S et al. Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. Diabetologia. 2008;51(7):1276–84.CrossRefPubMed
11.
Zurück zum Zitat Reaven GM et al. Measurement of plasma-glucose, free fatty-acid, lactate, and insulin for 24-H in patients with NIDDM. Diabetes. 1988;37(8):1020–4.CrossRefPubMed Reaven GM et al. Measurement of plasma-glucose, free fatty-acid, lactate, and insulin for 24-H in patients with NIDDM. Diabetes. 1988;37(8):1020–4.CrossRefPubMed
12.
Zurück zum Zitat Yue KT et al. Effect of glucose on plasma concentrations of individual non-esterified fatty acids of non-diabetic and insulin-independent diabetic men. Postgrad Med J. 1981;57(672):622–6.CrossRefPubMedPubMedCentral Yue KT et al. Effect of glucose on plasma concentrations of individual non-esterified fatty acids of non-diabetic and insulin-independent diabetic men. Postgrad Med J. 1981;57(672):622–6.CrossRefPubMedPubMedCentral
13.
14.
Zurück zum Zitat Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM—genetic and clinical implications. Diabetes. 1995;44(8):863–70.CrossRefPubMed Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM—genetic and clinical implications. Diabetes. 1995;44(8):863–70.CrossRefPubMed
15.
Zurück zum Zitat McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 1999;42(2):128–38.CrossRefPubMed McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 1999;42(2):128–38.CrossRefPubMed
16.
Zurück zum Zitat Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin-secretion and B-cell oxidation through a process likely coupled to fatty-acid oxidation. Endocrinology. 1990;127(4):1580–9.CrossRefPubMed Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin-secretion and B-cell oxidation through a process likely coupled to fatty-acid oxidation. Endocrinology. 1990;127(4):1580–9.CrossRefPubMed
17.
Zurück zum Zitat Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46(1):3–10.CrossRefPubMed Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46(1):3–10.CrossRefPubMed
19.
Zurück zum Zitat Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23(12):1994–2003.CrossRefPubMed Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23(12):1994–2003.CrossRefPubMed
20.
Zurück zum Zitat Bierman EL, Schwartz IL, Dole VP. Action of insulin on release of fatty acids from tissue stores. Am J Physiol. 1957;191(2):359–62.PubMed Bierman EL, Schwartz IL, Dole VP. Action of insulin on release of fatty acids from tissue stores. Am J Physiol. 1957;191(2):359–62.PubMed
21.
Zurück zum Zitat Hirsch J, Goldrick RB. Serial studies on the metabolism of human adipose tissue. I. Lipogenesis and free fatty acid uptake and release in small aspirated samples of subcutaneous fat. J Clin Invest. 1964;43:1776–92.CrossRefPubMedPubMedCentral Hirsch J, Goldrick RB. Serial studies on the metabolism of human adipose tissue. I. Lipogenesis and free fatty acid uptake and release in small aspirated samples of subcutaneous fat. J Clin Invest. 1964;43:1776–92.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Gray DS et al. Changes in individual plasma free fatty acids in obese females during fasting and refeeding. Int J Obes. 1991;15(2):163–8.PubMed Gray DS et al. Changes in individual plasma free fatty acids in obese females during fasting and refeeding. Int J Obes. 1991;15(2):163–8.PubMed
23.
Zurück zum Zitat Van Cauter E et al. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41(3):368–77.CrossRefPubMed Van Cauter E et al. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41(3):368–77.CrossRefPubMed
24.
Zurück zum Zitat Lee WJ et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.CrossRefPubMed Lee WJ et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.CrossRefPubMed
25.
26.
Zurück zum Zitat Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25(2):358–63.CrossRefPubMed Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25(2):358–63.CrossRefPubMed
27.
Zurück zum Zitat Ballantyne GH et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16(9):1189–97.CrossRefPubMed Ballantyne GH et al. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2006;16(9):1189–97.CrossRefPubMed
28.
Zurück zum Zitat Camastra S et al. Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care. 2007;30(4):1002–4.CrossRefPubMed Camastra S et al. Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care. 2007;30(4):1002–4.CrossRefPubMed
29.
Zurück zum Zitat Mari A et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia. 2006;49(9):2136–43.CrossRefPubMed Mari A et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia. 2006;49(9):2136–43.CrossRefPubMed
30.
Zurück zum Zitat Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care. 2009;32(3):514–20.CrossRefPubMedPubMedCentral Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care. 2009;32(3):514–20.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Yip S et al. Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction. Obes Surg. 2014;24(1):62–70.CrossRefPubMed Yip S et al. Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction. Obes Surg. 2014;24(1):62–70.CrossRefPubMed
Metadaten
Titel
Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes
verfasst von
Felicity Thomas
Greg C. Smith
Jun Lu
Richard Babor
Michael Booth
Grant Beban
J. Geoffrey Chase
Rinki Murphy
Publikationsdatum
04.01.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 8/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-015-2038-3

Weitere Artikel der Ausgabe 8/2016

Obesity Surgery 8/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.